Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.466 |
---|---|
High | 0.466 |
Low | 0.466 |
Bid | 0.47 |
Offer | 0.590 |
Previous close | 0.496 |
Average volume | 1.99k |
---|---|
Shares outstanding | 36.47m |
Free float | 36.25m |
P/E (TTM) | -- |
Market cap | 21.41m USD |
EPS (TTM) | -5.57 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 07:05 BST.
More ▼
Announcements
- Biora Therapeutics Achieves ISO 13485 Certification
- Biora Therapeutics Announces Positive Nasdaq Listing Decision
- Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- Biora Therapeutics Announces Funding Agreement with Existing Investors
- Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
- Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
- Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
- Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
- Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
More ▼